The following is a guest blog post by Jim Pickett, chair of International Rectal Microbicides Advocates (IRMA) and director of Prevention Advocacy and Gay Men’s Health at the AIDS Foundation of Chicago.
Since 2005, our network of more than 1,000 scientists, advocates, policymakers, and funders from six continents that makes up International Rectal Microbicide Advocates (IRMA), has advocated for the accelerated research and development of safe, effective, acceptable and accessible rectal microbicides for the women, men, and transgender individuals around the world who engage in anal intercourse…. (Read More)
In honor of World Health Day 2011 (April 7), the World Health Organization (WHO) released a six-point policy package to combat the spread of antimicrobial resistance, a problem the organization says is not new but is becoming increasingly burdensome, dangerous and costly. “The world is on the brink of losing these miracle cures,” said WHO […]
The Medicines Patent Pool launched a new resource this week – a database with searchable patent information on 23 antiretroviral (ARV) drugs, including some pipeline products, in 67 countries. Developed in collaboration with the World Intellectual Property Organization and 29 national and regional patent offices, making information on who is legally able to manufacture or […]
“Taking medication is not easy. The pills taste bad and they make my stomach upset. After I take them, I don’t like anyone to talk to me. It takes a while before I feel better. I know it is my obligation and responsibility, but how much longer must I take them?”
Those are the words of a nine-year-old multidrug-resistant tuberculosis (MDR-TB) patient who passed away shortly thereafter, becoming one of 250,000 children around the world who die of TB every year. They were relayed by Rachel Orduño, a TB patient advocate with The TB Photovoice Project, at a briefing entitled “Accelerating Progress to Combat TB: Innovation and Partnership,”… (Read More)
Ambassador Eric Goosby, U.S. Global AIDS Coordinator, has announced a one-time $20 million investment to develop and initiate an innovative, integrated TB/HIV care package in targeted countries with a significant burden of TB/HIV co-infection. This is part of an overall investment of $160 million in PEPFAR resources to combat TB/HIV. The eligible PEPFAR countries are […]
The following is a guest blog post by Dr. Madhukar Pai, a professor and TB researcher based at McGill University in Montreal, Canada. He serves as co-chair of the Stop TB Partnership’s New Diagnostics Working Group (NDWG), and as a consultant to the Bill & Melinda Gates Foundation (BMGF).
Here is a real story that played out in India. 25-year-old Mohan from Chhattisgarh state had been ill with cough, fever, and weight loss for a number of weeks. He had all the classic symptoms of TB when he went to a private doctor in his town for help. The doctor advised him to… (Read More)
In front of a packed audience at the Kaiser Family Foundation, South African Minister of Health Dr. Aaron Motsoaledi painted a picture of South Africa showing that while significant progress is being made, the war against AIDS is far from over.
In some districts of KwaZulu-Natal (KZN) province, HIV prevalence is as high as 46 percent. The death rate in the country doubled from 1997 to 2006 – six out of 10 deaths in 2006 were AIDS-related. And maternal mortality is getting worse – 59 percent of women who died during childbirth were posthumously tested for HIV from 2005-2007, 79 percent of those tested were HIV infected. Among HIV-negative women in South Africa, 34 out of every 100,000 live births result in the mother dying. Among HIV-positive women, that number jumps nearly 10 times… (Read More)